eureKARE appoints Anne Lauvergeon as a new Board member eureKARE appoints Anne Lauvergeon as a new Board member Luxembourg, Belgium, and Paris, France – 8 February 2023: eureKARE, an innovative investment company for disruptive synthetic biology...

eureKARE participates in DNA Script’s $200 Million Series C Financing eureKARE participates in DNA Script’s $200 Million Series C Financing Fundraise will accelerate commercial launch of revolutionary enzymatic DNA printing technology Luxembourg and Paris, France –...

eureKARE announces participation of the European Innovation Council in the opening of the eureKAWARDS eureKARE announces participation of the European Innovation Council in the opening of the eureKAWARDS Dr Iordanis Arzimanoglou, European Innovation Council Programme Manager for Health and...

eureKARE launches inaugural eureKAWARDS to support European synthetic biology innovation eureKARE launches inaugural eureKAWARDS to support European synthetic biology innovation Opportunity to showcase ground-breaking ideas, concepts, and business plans in front of Europe’s leading...

eureKARE appoints Clement Tallec as Chief Financial Officer eureKARE appoints Clement Tallec as Chief Financial Officer Paris, France – 16 July 2021: eureKARE ("the Company"), a pioneering new company focused on financing and building next generation...